Welcome to our dedicated page for Protokinetix SEC filings (Ticker: PKTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
protokinetix inc (pktx) is a company based out of 2225 folkestone way, west vancouver, bc, canada.ProtoKinetix, Inc. filed a Form D claiming Regulation D exemptions (Rule 506(b) and Securities Act Section 4(a)(5)) for an equity offering with a total target amount of $100,000. The issuer reports $5,000 sold to date and $95,000 remaining, with one investor already participating and a stated minimum investment of $0. The offering is not intended to last more than one year and is not tied to any business combination. The filing lists key officers: Clarence Smith identified as President and CEO, Michael Guzzetta as CFO (and signer), and Edward McDonough as a director. The issuer's principal place of business is 109 W. Main St., Dalton, Ohio 44618. The filing reports no sales commissions or finders' fees and indicates no proceeds will be paid to named executives or directors.
ProtoKinetix, Inc. filed a Definitive Proxy Statement (Form DEF 14A) identifying key corporate actors and major shareholders while including signature and consent language. Clarence E. Smith is listed as President and Director signing the document. The filing discloses a large individual holding of 27,700,776 shares owned directly by Alexandra Smith and a joint holding of 23,458,709 shares owned directly by John and Edith Smith, with principal addresses provided. The document includes checklist items for filing fees and references fiscal year periods ending December 31, 2024, March 31, 2025, and June 30, 2025 along with their SEC filing dates. The text also shows a voting response option marked as "CONSENT WITHHELD (\u201cAGAINST\u201d)".
FAQ
What is the current stock price of Protokinetix (PKTX)?
What is the market cap of Protokinetix (PKTX)?
